Mar 18, 2022, 01:00 AM by User Not Found

Bio-IT World | Nearly 100,000 highly diverse whole genome sequences are now available through the National Institutes of Health's All of Us Research Program, the NIH announced today. About 50% of the data is from individuals who identify with racial or ethnic groups that have historically been underrepresented in research. This data will enable researchers to address yet unanswerable questions about health and disease, leading to new breakthroughs and advancing discoveries to reduce persistent health disparities.

Mar 17, 2022, 12:27 PM by

Mar 17, 2022, 12:27 PM by

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

Mar 17, 2022, 12:27 PM by

Creative Peptides announces the release of innovative peptide drug discovery services to support and assist global clients in winning the race of peptide drug development.

Mar 17, 2022, 12:27 PM by

Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.

Mar 17, 2022, 12:27 PM by

Creative Peptides provides useful approaches for labeling peptides with fluorescent dyes

Mar 17, 2022, 12:27 PM by

Lyniate and NextGate have entered into a merger agreement.

Mar 17, 2022, 12:27 PM by

ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.

Mar 17, 2022, 12:27 PM by

Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 14, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”

Mar 17, 2022, 12:27 PM by

Mar 17, 2022, 12:27 PM by

Decentralized Clinical Trial Platform Provider Welcomes 100th Teammate

Mar 17, 2022, 12:27 PM by

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

Mar 17, 2022, 12:27 PM by

Cloud-based software platform PubHive Navigator now supports auto-scheduling of aggregate safety reports plus bulk assignments of responsible report owners

Mar 17, 2022, 12:27 PM by

physIQ, a pioneer in digital medicine, and CellCarta, a global leader in precision medicine services, announce a strategic collaboration to undertake a groundbreaking study with the potential to revolutionize vaccine development.

Mar 17, 2022, 01:00 AM by User Not Found

Bio-IT World | The Bio-IT World Conference & Expo kicks off the first week in May, back in its pre-pandemic Spring timeslot. We are looking forward to joining the Bio-IT community both in person and virtually and exploring the progress the community has made over the past two years. While the program is packed full of sessions to flag, here are the sessions outside of the track schedule that we are highlighting

Mar 15, 2022, 15:27 PM by User Not Found

Bio-IT World | Element Biosciences has launched the Element AVITI System, a benchtop sequencer offering an unrivaled combination of performance, cost, and flexibility. Element’s proprietary Avidity Sequencing chemistries enable exceptional accuracy and cost efficiency that is unmatched by other benchtop systems, according to the company.

Mar 11, 2022, 14:10 PM by

Curebase and CoBTeK (team from Côte d’Azur) to Collaborate on a European Clinical Trial of Remote Tools Designed to Help Seniors Retain Autonomy

Mar 11, 2022, 14:09 PM by

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance.

Mar 11, 2022, 14:09 PM by

Mar 11, 2022, 14:09 PM by

As a reliable computational biology service provider based in New York, CD ComputaBio has recently launched homology modeling service to help researchers deeply understand the structure-activity relationship of the target protein, and provide strong support for structure-based rational drug design, protein function research, and protein engineering research. Relying on its professional team and advanced technology, as well as high-quality products and services, CD ComputaBio has gained a solid reputation.